Striking follicular eruption to pegylated liposomal doxorubicin

Julia Dai, Robert Micheletti, Misha Rosenbach, Emily Y. Chu

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The adverse effects of pegylated liposomal doxorubicin are primarily cutaneous. The majority of these cutaneous side effects manifest as palmar-plantar erythrodysesthesia, whereas few reports of other cutaneous reactions exist in the literature. The authors report a case of an exuberant follicular eruption in a patient treated with pegylated liposomal doxorubicin. This case also highlights the potential mechanism underlying this unusual histological and clinical reaction.

Original languageEnglish (US)
Pages (from-to)590-591
Number of pages2
JournalAmerican Journal of Dermatopathology
Volume36
Issue number7
DOIs
StatePublished - Jul 2014
Externally publishedYes

Keywords

  • follicular rash
  • pegylated liposomal doxorubicin

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dermatology

Fingerprint

Dive into the research topics of 'Striking follicular eruption to pegylated liposomal doxorubicin'. Together they form a unique fingerprint.

Cite this